Stocks · Health care · Surgical & Medical Instruments & Apparatus

Beta Bionics, Inc.

BBNX Clue Score57
United States Fiscal year ends December CIK 0001674632 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Stephen Feider
29 Jun 2026
Chief Financial Officer
Sold after exercise
4,896
$17.03
$83.38K
Stephen Feider
26 Jun 2026
Chief Financial Officer
Sold after exercise
5,104
$17.05
$87.01K
Stephen Feider
2 Jan 2026
Chief Financial Officer
Sold after exercise
20,000
$29.53
$590.68K
Stephen Feider
3 Oct 2025
Chief Financial Officer
Sold after exercise
1,154
$22.28
$25.71K
Stephen Feider
3 Oct 2025
Chief Financial Officer
Sold after exercise
3,828
$21.52
$82.37K
Stephen Feider
1 Oct 2025
Chief Financial Officer
Sold after exercise
100
$21.08
$2.11K
Stephen Feider
1 Oct 2025
Chief Financial Officer
Sold after exercise
14,918
$20.76
$309.70K
Stephen Feider
8 Sep 2025
Chief Financial Officer
Sold after exercise
9,900
$21.13
$209.15K
Stephen Feider
5 Sep 2025
Chief Financial Officer
Sold after exercise
100
$21.00
$2.10K
Mark Hopman
5 Sep 2025
Chief Commercial Officer
Sold after exercise
11,411
$20.56
$234.66K
Mark Hopman
4 Sep 2025
Chief Commercial Officer
Sold after exercise
6,818
$19.97
$136.18K
Stephen Feider
22 Aug 2025
Chief Financial Officer
Sold after exercise
4,413
$17.01
$75.08K
Stephen Feider
19 Aug 2025
Chief Financial Officer
Sold after exercise
5,587
$17.03
$95.17K
Mark Hopman
19 Aug 2025
Chief Commercial Officer
Sold after exercise
16,158
$16.61
$268.38K
Mike Mensinger
31 Jan 2025
Chief Product Officer
Sold after exercise
13
$17.00
$221.00

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 15
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 4,286,158
History held since 31 Jan 2025